EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents

Sijongesonke Peter iD, Blessing Atim Aderibigbe iD

Molecules · 2023

DOI: 10.3390/molecules28196889 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Sijongesonke Peter und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Fort Hare, Alice 5700, South Africa. Hauptthemen laut MEDLINE: Antineoplastic Agents, Breast Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Medical Research Council, University of Fort Hare, National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increasing cases of cancer have been a primary concern in recent decades. Developing new chemotherapeutics is challenging and has been faced with limitations, such as multidrug resistance, poor specificity, selectivity, and toxicity. The aforementioned factors contribute to treatment failure. Hybrid compounds have features that can overcome the limitations mentioned above. Chlorambucil, an anticancer drug that is used to treat prostate and breast cancer, suffers from poor aqueous solubility and specificity, a short half-life, and severe side effects, including anaemia and bone marrow suppression. It compromises the immune system, resulting in treatment failure. Hence, its combination with other pharmacophores has been reported to result in effective anticancer agents with fewer side effects and high therapeutic outcomes. Furthermore, this review gives an update (2010 to date) on the developments of chlorambucil hybrid compounds with anticancer activity, and the structure-activity relationship (SAR), and also highlights future strategies for developing novel anticancer agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsBreast NeoplasmsMaleHumansChlorambucilStructure-Activity RelationshipPharmacophore

Stichwörter der Autor:innen

cancerchlorambucildrug resistancehybridizationtreatment

Substanzen

ChlorambucilAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry, University of Fort Hare, Alice 5700, South Africa.

ORCID-Profile: Sijongesonke Peter, Blessing Atim Aderibigbe

Förderung

  • South African Medical Research Council
  • University of Fort Hare
  • National Research Foundation

Zitieren

APA

Peter, S., & Aderibigbe, B. A. (2023). Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents. Molecules. https://doi.org/10.3390/molecules28196889

Vancouver

Peter S, Aderibigbe BA. Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents. Molecules. 2023. doi:10.3390/molecules28196889

BibTeX
@article{Peter2023,
  author = {Peter, Sijongesonke and Aderibigbe, Blessing Atim},
  title = {Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28196889}
}
Kostenlos starten →